SCHEMBL14919686

SCHEMBL14919686

Cc1ccc(NS(=O)(=O)c2ccc3c4c(cccc24)C(=O)N3)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 5/20 0.77
KMT2A Q03164 4/20 0.76
MEN1 O00255 3/20 0.76
MAPT P10636 4/20 0.72
SMN1; SMN2 Q16637 3/20 0.72
TP53 P04637 2/20 0.72
PTPRB P23467 1/20 0.71
CDK5 Q00535 1/20 0.69
CDK5R1 Q15078 1/20 0.69
TNF P01375 1/20 0.66
CA1 P00915 1/20 0.65
CA2 P00918 1/20 0.65
CA9 Q16790 1/20 0.65
KDM4E B2RXH2 3/20 0.65
ALDH1A1 P00352 3/20 0.65
HPGD P15428 3/20 0.65
POLB P06746 3/20 0.64
GAA P10253 2/20 0.64
PKM P14618 1/20 0.63
HSD17B10 Q99714 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13940909 0.94 RORC (0.86) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL13941123 0.88 RORC (0.77) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL13941130 0.87 MAPT (0.71) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL13941129 0.84 RORC (0.74) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL13941141 0.84 MAPT (1.00) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL13941140 0.83 MAPT (0.72) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL13941122 0.82 TNF (0.82) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL13941133 0.82 MAPT (0.78) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL13941728 0.82 POLB (0.70) RORCKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL15798277 0.82 CDK5 (1.00) RORCKMT2AMEN1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013066469-A2 KINASE INHIBITORS CAPABLE OF INCREASING THE SENSITIVITY OF BACTERIAL PATHOGENS TO B-LACTAM ANTIBIOTICS SEATTLE CHILDREN'S RESEARCH INSTITUTE (US) 2013-05-10 WO claimed
WO-2013066469-A2 KINASE INHIBITORS CAPABLE OF INCREASING THE SENSITIVITY OF BACTERIAL PATHOGENS TO B-LACTAM ANTIBIOTICS SEATTLE CHILDREN'S RESEARCH INSTITUTE (US) 2013-05-10 WO disclosed